MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

Search

Alcon Inc

Closed

Sector Healthcare

90.28 0.91

Overview

Share price change

24h

Current

Min

89.69

Max

90.31

Key metrics

By Trading Economics

Income

40M

263M

Sales

-26M

2.5B

P/E

Sector Avg

38.227

73.394

EPS

0.528

Dividend yield

0.3

Profit margin

10.717

Employees

25,000

EBITDA

-300M

341M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+12.19 upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.30%

3.09%

Next Earnings

25 Feb 2025

Market Stats

By TradingEconomics

Market Cap

3.2B

45B

Previous open

89.37

Previous close

90.28

News Sentiment

By Acuity

61%

39%

335 / 393 Healthcare

Technical Score

By Trading Central

Confidence

Neutral Evidence

Alcon Inc Chart

Past performance is not a reliable indicator of future results.

Related News

12 Nov 2024, 18:48 UTC

Earnings
Major Market Movers

Alcon Posts Higher 3Q Sales and Profit, Lowers 2024 Sales View

14 May 2024, 08:28 UTC

Earnings
Major Market Movers

Alcon's Swiss Shares Jump After Contact-Lense Sales Boost Earnings

17 Dec 2024, 15:05 UTC

Market Talk

Alcon's Late-Stage Pipeline Set To Drive Revenue Growth Next Year -- Market Talk

12 Nov 2024, 17:38 UTC

Earnings

Alcon Narrows 2024 View To Adj EPS $3.00-Adj EPS $3.05 >ALC

12 Nov 2024, 17:38 UTC

Earnings

Alcon Had Seen 2024 Sales $9.9B-$10.1B >ALC

12 Nov 2024, 17:37 UTC

Earnings

Alcon Cuts 2024 View To Sales $9.8B-$9.9B >ALC

12 Nov 2024, 17:36 UTC

Earnings

Alcon 3Q Core Operating Margin 20.6% >ALC

12 Nov 2024, 17:36 UTC

Earnings

Alcon 3Q Sales $2.43B >ALC

12 Nov 2024, 17:36 UTC

Earnings

Alcon 3Q Adj EPS 81c >ALC

12 Nov 2024, 17:35 UTC

Earnings

Alcon 3Q EPS 53c >ALC

12 Nov 2024, 17:35 UTC

Earnings

Alcon 3Q Rev $2.45B >ALC

21 Aug 2024, 07:01 UTC

Market Talk
Earnings

Alcon's Transformation Is Paying Off -- Market Talk

20 Aug 2024, 20:36 UTC

Earnings

Alcon 2Q Sales $2.482B >ALC.EB

20 Aug 2024, 20:36 UTC

Earnings

Alcon Sees 2024 Sales $9.9B-$10.1B >ALC.EB

20 Aug 2024, 20:36 UTC

Earnings

Alcon 2Q EPS 45c >ALC.EB

14 May 2024, 07:44 UTC

Market Talk
Earnings

Alcon's Results Reduce Risk for Full Year -- Market Talk

13 May 2024, 20:33 UTC

Earnings

Alcon Backs 2024 Sales $9.9B-$10.1B >ALC.EB

13 May 2024, 20:33 UTC

Earnings

Alcon 1Q EPS 50c >ALC.EB

13 May 2024, 20:33 UTC

Earnings

Alcon 1Q Sales $2.4B >ALC.EB

13 May 2024, 20:32 UTC

Earnings

Alcon 1Q Rev $2.4B >ALC.EB

13 May 2024, 20:32 UTC

Earnings

Alcon 1Q EPS 50c >ALC.EB

27 Feb 2024, 21:34 UTC

Earnings

Alcon Sees 2024 Sales $9.9B-$10.1B >ALC.EB

27 Feb 2024, 21:33 UTC

Earnings

Alcon 4Q EPS 86c >ALC.EB

27 Feb 2024, 21:32 UTC

Earnings

Alcon 4Q Rev $2.35B >ALC.EB

Peer Comparison

Price change

Alcon Inc Forecast

Price Target

By TipRanks

12.19% upside

12 Months Forecast

Average 101.32 USD  12.19%

High 106 USD

Low 85 USD

Based on 9 Wall Street analysts offering 12 month price targets forAlcon Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

9 ratings

7

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

89.415 / 90.38Support & Resistance

Short Term

Neutral Evidence

Intermediate Term

Bullish Evidence

Long Term

Weak Bullish Evidence

Sentiment

By Acuity

335 / 393 Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Alcon Inc

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.